News & Views
Bill Burns Appointed as Non Executive Director
May 07 2010
Shire plc (Dublin) a specialty biopharmaceutical company has appointed Bill Burns to its Board as a Non Executive Director with immediate effect. Mr Burns has also been appointed a member of Shire’s Remuneration Committee. Mr Burns has a long and distinguished career in the global pharmaceuticals industry, most recently as CEO of Roche’s Pharmaceuticals Division and as a member of the Roche Group Corporate Executive Committee. He was involved in the acquisition and privatisation of Genentech, led the integration of Boehringer Mannheim Therapeutics and played a lead role in the negotiations resulting in Roche becoming a majority owner of Chugai in Japan. Following retirement in January this year, he has since been appointed to the Board of Directors of Roche Holdings Ltd and is a Board member of bothChugai Pharmaceuticals and of Genentech Inc.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark